Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol.


Journal

Nutrition (Burbank, Los Angeles County, Calif.)
ISSN: 1873-1244
Titre abrégé: Nutrition
Pays: United States
ID NLM: 8802712

Informations de publication

Date de publication:
06 2020
Historique:
received: 25 03 2020
accepted: 26 03 2020
pubmed: 14 4 2020
medline: 20 5 2020
entrez: 14 4 2020
Statut: ppublish

Résumé

Beginning in December 2019, the 2019 novel coronavirus disease (COVID-19) has caused a pneumonia epidemic that began in Wuhan, China, and is rapidly spreading throughout the whole world. Italy is the hardest hit country after China. Considering the deleterious consequences of malnutrition, which certainly can affect patients with COVID-19, the aim of this article is to present a pragmatic protocol for early nutritional supplementation of non-critically ill patients hospitalized for COVID-19 disease. It is based on the observation that most patients present at admission with severe inflammation and anorexia leading to a drastic reduction of food intake, and that a substantial percentage develops respiratory failure requiring non-invasive ventilation or even continuous positive airway pressure. High-calorie dense diets in a variety of different consistencies with highly digestible foods and snacks are available for all patients. Oral supplementation of whey proteins as well as intravenous infusion of multivitamin, multimineral trace elements solutions are implemented at admission. In the presence of 25-hydroxyvitamin D deficit, cholecalciferol is promptly supplied. If nutritional risk is detected, two to three bottles of protein-calorie oral nutritional supplements (ONS) are provided. If <2 bottles/d of ONS are consumed for 2 consecutive days and/or respiratory conditions are worsening, supplemental/total parenteral nutrition is prescribed. We are aware that our straight approach may be debatable. However, to cope with the current emergency crisis, its aim is to promptly and pragmatically implement nutritional care in patients with COVID-19, which might be overlooked despite being potentially beneficial to clinical outcomes and effective in preventing the consequences of malnutrition in this patient population.

Identifiants

pubmed: 32280058
pii: S0899-9007(20)30118-0
doi: 10.1016/j.nut.2020.110835
pmc: PMC7194616
pii:
doi:

Substances chimiques

Whey Proteins 0
Vitamin D 1406-16-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110835

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors have no conflicts of interest to declare.

Références

Am J Physiol Lung Cell Mol Physiol. 2015 Jun 15;308(12):L1189-201
pubmed: 25888573
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Respir Care. 2017 Aug;62(8):1119-1120
pubmed: 28733319
JAMA. 2013 Nov 27;310(20):2154-63
pubmed: 24281460
Lancet. 2020 Mar 21;395(10228):e52
pubmed: 32171074
Chin Med J (Engl). 2020 May 5;133(9):1032-1038
pubmed: 32118640
Sci Rep. 2019 Oct 22;9(1):15157
pubmed: 31641172
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Br J Nutr. 2001 May;85 Suppl 2:S67-74
pubmed: 11509092
Lancet. 2019 Jun 8;393(10188):2312-2321
pubmed: 31030981
Oxid Med Cell Longev. 2017;2017:9834803
pubmed: 28421130
J Clin Med. 2019 May 31;8(6):
pubmed: 31159248
Proc Nutr Soc. 2017 Aug;76(3):347-351
pubmed: 27821203
Intensive Care Med. 2020 May;46(5):854-887
pubmed: 32222812
Clin Nutr. 2008 Feb;27(1):5-15
pubmed: 18061312
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Arch Virol. 2017 Apr;162(4):907-917
pubmed: 28039563
Nutr Rev. 1998 Jan;56(1 Pt 2):S140-6
pubmed: 9481136
Cancer Med. 2019 Nov;8(16):6923-6932
pubmed: 31568698
J Assoc Nurses AIDS Care. 2017 Nov - Dec;28(6):984-986
pubmed: 28916144
Pharmacol Res. 2019 Jun;144:245-256
pubmed: 31005617
Clin Nutr. 2018 Feb;37(1):336-353
pubmed: 28802519
Respir Care. 2017 Apr;62(4):459-467
pubmed: 27923936
Curr Opin Clin Nutr Metab Care. 2011 Nov;14(6):562-8
pubmed: 21986479
Appl Microbiol Biotechnol. 2015 Sep;99(17):6997-7008
pubmed: 26198883
Int J Mol Sci. 2018 Aug 16;19(8):
pubmed: 30115864
Front Immunol. 2018 Mar 12;9:458
pubmed: 29593721
Sci Rep. 2016 May 16;6:25835
pubmed: 27180604
Nutrition. 2020 Apr;72:110667
pubmed: 31962189
J Clin Virol. 2011 Mar;50(3):194-200
pubmed: 21242105
Crit Care. 2018 Feb 6;22(1):27
pubmed: 29409542
Arch Virol. 2017 Mar;162(3):603-610
pubmed: 27848013
Br J Nutr. 2000 Nov;84 Suppl 1:S81-9
pubmed: 11242451
Microbes Infect. 2017 Dec;19(12):580-586
pubmed: 28918004
JAMA. 2013 May 22;309(20):2130-8
pubmed: 23689848
J Am Coll Nutr. 2001 Oct;20(5 Suppl):384S-388S; discussion 396S-397S
pubmed: 11603647
J Infect Dis. 2014 Jul 15;210(2):244-53
pubmed: 24799602
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Mil Med Res. 2020 Feb 6;7(1):4
pubmed: 32029004
Rev Med Virol. 2019 Mar;29(2):e2032
pubmed: 30614127
JAMA. 2012 Oct 17;308(15):1535-44
pubmed: 23073950
Am J Gastroenterol. 2020 May;115(5):766-773
pubmed: 32287140
PLoS Pathog. 2019 Nov 11;15(11):e1008089
pubmed: 31710653
BMJ. 2014 May 15;348:g3187
pubmed: 25134117
Cells. 2019 Jun 17;8(6):
pubmed: 31212984
BMC Infect Dis. 2019 Jun 18;19(1):537
pubmed: 31215397
Dig Dis Sci. 2015 Aug;60(8):2236-45
pubmed: 25772777
Br J Nutr. 2009 Mar;101(5):633-58
pubmed: 18814803
Proc Nutr Soc. 2010 Nov;69(4):565-73
pubmed: 20441676
Int J Mol Sci. 2019 Oct 11;20(20):
pubmed: 31614433
J Med Virol. 2020 May;92(5):479-490
pubmed: 32052466

Auteurs

Riccardo Caccialanza (R)

Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Electronic address: r.caccialanza@smatteo.pv.it.

Alessandro Laviano (A)

Department of Translational and Precision Medicine, La Sapienza University, Rome, Italy.

Federica Lobascio (F)

Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Elisabetta Montagna (E)

Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Raffaele Bruno (R)

Division of Infectious Diseases Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Medical, Surgical, Diagnostic and Paediatric Science, University of Pavia, Pavia, Italy.

Serena Ludovisi (S)

Division of Infectious Diseases Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Medical, Surgical, Diagnostic and Paediatric Science, University of Pavia, Pavia, Italy.

Angelo Guido Corsico (AG)

Pneumology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.

Antonio Di Sabatino (A)

First Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.

Mirko Belliato (M)

UOS Advanced Respiratory Intensive Care Unit, UOC Anestesia e Rianimazione 1, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Monica Calvi (M)

Pharmacy Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Isabella Iacona (I)

Pharmacy Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Giuseppina Grugnetti (G)

Nursing Technical and Rehabilitation Service, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Elisa Bonadeo (E)

UOC Direzione Medica di Presidio, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Alba Muzzi (A)

UOC Direzione Medica di Presidio, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Emanuele Cereda (E)

Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH